Related Experiment Video
Updated: Oct 14, 2025

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Cardiovascular event risk estimated by myocardial perfusion SPECT combined with clinical data
Tomohiko Sakatani1, Kenichi Nakajima2, Tsunehiko Nishimura3
1Department of Cardiology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
Insights
Myocardial scintigraphy aids in diagnosing coronary artery disease and assessing cardiac event risk. Combining scintigraphy with clinical data improves prognosis stratification and treatment decisions for stable angina patients.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Myocardial scintigraphy is crucial for diagnosing coronary artery disease (CAD), risk stratification, and treatment planning.
- Recent trials question the universal benefit of coronary intervention for stable angina.
- Accurate risk assessment is vital for guiding patient management.
Purpose of the Study:
- To review risk estimation for cardiac events using the Japanese Assessment of Cardiac Events and Survival Study by Quantitative Gated SPECT (J-ACCESS).
- To highlight the combined utility of scintigraphy and clinical features for improved prognostic stratification.
- To inform treatment policy determination in patients with stable angina.
Main Methods:
- Review of data and findings from the J-ACCESS study.
- Analysis of myocardial scintigraphy parameters.
- Integration of clinical features with imaging data for risk assessment.
Main Results:
- The J-ACCESS study provides a framework for estimating cardiac event risks.
- Combining myocardial scintigraphy with clinical data enhances prognostic accuracy.
- This integrated approach supports more precise treatment policy decisions.
Conclusions:
- Myocardial scintigraphy, particularly when combined with clinical features, offers valuable insights for managing stable angina.
- Accurate risk stratification using J-ACCESS data and imaging improves patient outcomes.
- Personalized treatment strategies can be developed based on comprehensive risk assessment.
Abstract:
Myocardial scintigraphy plays important roles in the diagnosis of coronary artery disease, prognostic risk stratification, and determination of the treatment policy. Recently, several large-scale clinical trials reported that coronary intervention was not necessarily advantageous for preventing future cardiac events in patients with stable angina. This review summarizes how we can estimate cardiac event risks based on Japanese Assessment of Cardiac Events and Survival Study by Quantitative Gated SPECT (J-ACCESS), and describes that the combination of scintigraphy and other clinical features leads to more accurate stratification of prognosis and the determination of subsequent treatment policy.
More Related Videos
11:09High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
08:51Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
Published on: May 12, 2019
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT